4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-024842
Chief Executive Officer gave up 19,110 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-04-18 | Shares withheld for taxes | −19,110 | $0.92 | $17,581 | 4,014,257 | D |
Loading xslF345X03/doc4.xml…